Emerald Health Therapeutics (TSXV:EMH) has provided a corporate update on its recently closed and oversubscribed bought deal financing, together with a vision for growth in 2017.
As quoted in the press release:
“Following our successful financing with Dundee Capital Partners, Emerald is well capitalized and prepared for an exciting year of growth. Led by one of the industry’s most experienced scientific development teams, our focus has remained on downstream product development. From day one, Emerald has operated with the mandate of “enhancing health through cannabis science” and it’s these principles that will guide us as we forge ahead with our exciting and aggressive growth initiatives,” says Avtar Dhillon, MD, Executive Chairman of Emerald.
Significant expansion planned on 32-acre site in Metro Vancouver
As Emerald has been planning expansion, much of its research and development focus has involved increasing plant diversity and product offerings, as well as improving on its cultivation, manufacturing, and standardization processes in anticipation of a significant scale up. As the fifth applicant and eighth Licensed Producer in Canada, from the beginning Emerald has focused on quality of cultivation over quantity backed by strong research and development.
Phase 1 Expansion:
- Plans are well underway to break ground in Q1 2017 to add 50,000 sq. ft. of cultivation space
- This will be a state-of-the-art purpose built facility with anticipated capacity in excess of 5,000 kg per annum
- Emerald’s first harvest is anticipated in early 2018 and will be ready for sale upon licensing
Phase 2 Expansion:
- Emerald plans to scale-up in a modular fashion, with 50,000 sq. ft. additions to minimize the risk of product quality issues
- Construction on Phase 2 to add an additional 50,000 sq. ft. of production area is anticipated to begin shortly after the commencement of Phase 1 and will be ready for production in 2018
The Company has the capacity to build out an aggregate of 1 million sq. ft. of total production space on its 32-acre Metro Vancouver property.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .